[Long-term hemodialysis and changes in variables of coagulation and fibrinolysis]

Y Uchida1

  • 1Second Department of Internal Medicine, Faculty of Medicine, Kagoshima University.

Fukuoka Igaku Zasshi = Hukuoka Acta Medica
|November 1, 1991
PubMed

Insights

Long-term hemodialysis patients exhibit increased coagulability and decreased fibrinolytic capacity, elevating thrombosis risk. This study highlights impaired vascular endothelial function with extended hemodialysis duration.

Area of Science:

  • Nephrology
  • Vascular Biology
  • Hematology

Context:

  • Hemodialysis (HD) significantly improves outcomes for chronic kidney disease patients.
  • Prolonged HD treatment is associated with vascular complications, including thrombosis.
  • Understanding endothelial function is crucial for managing thrombosis risk in long-term HD patients.

Purpose:

  • To investigate changes in coagulation and fibrinolysis markers in hemodialysis patients.
  • To assess vascular endothelial function, specifically tissue plasminogen activator (t-PA) and plasminogen activator inhibitor-1 (PAI-1) levels.
  • To determine the impact of hemodialysis duration on these markers and thrombosis risk.

Summary:

  • HD patients showed higher levels of Fibrinopeptide A (FPA), thrombin-antithrombin III complex (TAT), and D-dimer compared to controls, indicating increased coagulability.
  • Antithrombin III (AT III) levels were lower, and tissue plasminogen activator (t-PA) activity and antigen levels were significantly reduced in HD patients.
  • FPA levels and thrombosis risk increased with longer hemodialysis duration, while t-PA activity decreased, correlating negatively with treatment duration.

Impact:

  • Findings suggest that long-term hemodialysis impairs vascular endothelial fibrinolytic capacity, increasing thrombosis risk.
  • The study identifies key biomarkers for monitoring thrombosis risk in hemodialysis patients.
  • This research underscores the need for strategies to mitigate vascular damage and thrombosis in patients undergoing prolonged hemodialysis.

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this measurement...